Novavax Inc
(NVAX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 682,162 | 983,705 | 1,981,872 | 1,146,290 | 475,598 |
| Cost of Goods | 202,739 | 343,768 | 902,639 | N/A | N/A |
| Gross Profit | 479,423 | 639,937 | 1,079,233 | 1,146,290 | 475,598 |
| Operating Expenses | 729,093 | 1,207,216 | 1,724,608 | 2,832,866 | 892,317 |
| Operating Income | -248,931 | -566,511 | -644,736 | -1,686,576 | -416,719 |
| Interest Expense | 20,075 | 14,416 | 19,880 | 21,127 | 15,145 |
| Other Income | 92,391 | 37,896 | 10,969 | -6,833 | 13,605 |
| Pre-tax Income | -176,615 | -543,031 | -653,647 | -1,714,536 | -418,259 |
| Income Tax | 10,884 | 2,031 | 4,292 | 29,215 | N/A |
| Net Income Continuous | -187,499 | -545,062 | -657,939 | -1,743,751 | -418,259 |
| Net Income | $-187,499 | $-545,062 | $-657,939 | $-1,743,751 | $-418,259 |
| EPS Basic Total Ops | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 |
| EPS Basic Continuous Ops | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 |
| EPS Diluted Total Ops | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 |
| EPS Diluted Continuous Ops | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 |
| EPS Diluted Before Non-Recurring Items | -1.23 | -5.41 | -8.42 | -23.44 | -7.27 |
| EBITDA(a) | $-200,435 | $-525,286 | $-615,682 | $-1,673,915 | $-411,834 |